Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-02

FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., supporting its regulatory approval status for tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lampit (nifurtimox)

Snippet

SUPPL AP for LAMPIT (NIFURTIMOX)